Bilaketaren emaitzak - Gee‐Chen Chang

Findu emaitzak
  1. 1
    Genetic Polymorphism of XRCC1 Arg399Gln Is Associated With Survival in Non–Small-Cell Lung Cancer Patients Treated With Gemcitabine/Platinum

    Genetic Polymorphism of XRCC1 Arg399Gln Is Associated With Survival in Non–Small-Cell Lung Cancer Patients Treated With Gemcitabine/Platinum nork Wei‐Yu Liao, Jin‐Yuan Shih, Gee‐Chen Chang, Yu-Kai Cheng, James Chih‐Hsin Yang, Yuh‐Min Chen, Chong‐Jen Yu

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer

    Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer nork Sheng-Yi Lin, Hsiu-Hui Chang, Yi-Hua Lai, Ching‐Hsiung Lin, Min-Hsuan Chen, Gee‐Chen Chang, Meng-Feng Tsai, Jeremy J.W. Chen

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy

    Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy nork Jen‐Yi Lee, Yee-Ming Lee, Gee‐Chen Chang, Sung‐Liang Yu, Wan-Yu Hsieh, Jeremy J.W. Chen, Huei‐Wen Chen, Pan‐Chyr Yang

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    P2.14-59 Osimertinib in EGFR T790M Advanced NSCLC: Analysis of Uncommon/Complex EGFR Mutations in a Real-World Study (ASTRIS)

    P2.14-59 Osimertinib in EGFR T790M Advanced NSCLC: Analysis of Uncommon/Complex EGFR Mutations in a Real-World Study (ASTRIS) nork Parneet Cheema, Antonio Passaro, Charles E. Martin, Marcello Tiseo, K. Park, Gee‐Chen Chang, Yang Hu, Byoung Chul Cho, Margarida S. Miranda, A. Fernandes, H. Freitas

    Argitaratua 2019
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer

    RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer nork Mei‐Chih Chen, Kun‐Chieh Chen, Gee‐Chen Chang, Ho Lin, Chun‐Chi Wu, Wei-Hsiang Kao, Chieh‐Lin Jerry Teng, Shih‐Lan Hsu, Tsung‐Ying Yang

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Tp53 determines the spatial dynamics of M1/M2 tumor-associated macrophages and M1-driven tumoricidal effects

    Tp53 determines the spatial dynamics of M1/M2 tumor-associated macrophages and M1-driven tumoricidal effects nork Yi‐Jing Hsiao, Min-Shu Hsieh, Gee‐Chen Chang, Yin-Chen Hsu, C Y Wang, Yan-Ming Chen, Yi-Ling Chen, Pan‐Chyr Yang, Sung‐Liang Yu

    Argitaratua 2025
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients

    PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients nork Kuo-Hsuan Hsu, Jeng‐Sen Tseng, Tsung‐Ying Yang, Kun‐Chieh Chen, Kang‐Yi Su, Sung‐Liang Yu, Jeremy J.W. Chen, Yen-Hsiang Huang, Gee‐Chen Chang

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Terpinen-4-ol Induces Apoptosis in Human Nonsmall Cell Lung Cancer In Vitro and In Vivo

    Terpinen-4-ol Induces Apoptosis in Human Nonsmall Cell Lung Cancer In Vitro and In Vivo nork Chieh‐Shan Wu, Yun‐Ju Chen, Jeremy J.W. Chen, Jeng‐Jer Shieh, Chia-Hsin Huang, Pei-Shan Lin, Gee‐Chen Chang, JingHua-Tsai Chang, Chi‐Chen Lin

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer

    The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer nork Ming‐Fang Wu, Chih-An Lin, Tzu‐Hang Yuan, Hsiang‐Yuan Yeh, Sheng‐Fang Su, Chin‐Lin Guo, Gee‐Chen Chang, Ker-Chau Li, Chao‐Chi Ho, Huei‐Wen Chen

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung Adenocarcinoma

    The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung Adenocarcinoma nork Pei-Fang Hung, Tse‐Ming Hong, Yi‐Chiung Hsu, Hsuan‐Yu Chen, Yih‐Leong Chang, Chen‐Tu Wu, Gee‐Chen Chang, Yuh‐Shan Jou, Szu‐Hua Pan, Pan‐Chyr Yang

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma

    A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma nork Tony Mok, Sarayut Lucien Geater, Wu‐Chou Su, Eng-Huat Tan, James Chih‐Hsin Yang, Gee‐Chen Chang, May Han, Philip Komarnitsky, Francis Payumo, Jennifer Garrus, Sandra Close, Keunchil Park

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma

    Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma nork Jeng‐Sen Tseng, Tsung‐Ying Yang, Chi‐Ren Tsai, Kun‐Chieh Chen, Kuo-Hsuan Hsu, Meen-Hsin Tsai, Sung‐Liang Yu, Kang‐Yi Su, Jeremy J.W. Chen, Gee‐Chen Chang

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target

    Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target nork Kuan-Chung Hsiao, Neng-Yao Shih, Hsun-Lang Fang, Tze‐Sing Huang, Ching-Chuan Kuo, Pei‐Yi Chu, Yi‐Mei Hung, Shao-Wen Chou, Yi-Yuan Yang, Gee‐Chen Chang, Ko-Jiunn Liu

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program

    Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program nork Solange Peters, Alessandra Curioni‐Fontecedro, Hovav Nechushtan, Jin‐Yuan Shih, Wei‐Yu Liao, Oliver Gautschi, Vito Spataro, Mojca Unk, James Chih‐Hsin Yang, Robert M. Lorence, Philippe Carrière, A. Cseh, Gee‐Chen Chang

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients with EGFR T790M-Positive NSCLC

    MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients with EGFR T790M-Positive NSCLC nork Yi‐Long Wu, Byoung Chul Cho, Qing Zhou, Gee‐Chen Chang, Liyan Jiang, Giulio Metro, Claudio Martín, Gilberto de Castro, Johan Vansteenkiste, David Vicente, A. Milner, James R. Rigas, Y. Chen, Mariano Provencio

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Pretreatment Epidermal Growth Factor Receptor (<i>EGFR</i>) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer

    Pretreatment Epidermal Growth Factor Receptor (<i>EGFR</i>) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Ca... nork Kang‐Yi Su, Hsuan‐Yu Chen, Ker-Chau Li, Min‐Liang Kuo, James Chih‐Hsin Yang, Wing‐Kai Chan, Bing‐Ching Ho, Gee‐Chen Chang, Jin‐Yuan Shih, Sung‐Liang Yu, Pan‐Chyr Yang

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    HOXA5 Inhibits Metastasis via Regulating Cytoskeletal Remodelling and Associates with Prolonged Survival in Non-Small-Cell Lung Carcinoma

    HOXA5 Inhibits Metastasis via Regulating Cytoskeletal Remodelling and Associates with Prolonged Survival in Non-Small-Cell Lung Carcinoma nork Chi-Chung Wang, Kang‐Yi Su, Hsuan‐Yu Chen, So-Yi Chang, Chi-Fan Shen, Chia-Hung Hsieh, Qi-Sheng Hong, Ching-Cheng Chiang, Gee‐Chen Chang, Sung‐Liang Yu, Jeremy J.W. Chen

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

    The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarc... nork Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng‐Sen Tseng, Kun‐Chieh Chen, Chia-Hung Hsu, Kang‐Yi Su, Jeremy J.W. Chen, Huei‐Wen Chen, Sung‐Liang Yu, Tsung‐Ying Yang, Gee‐Chen Chang

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report

    Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report nork James Chih‐Hsin Yang, Frances A. Shepherd, Dong‐Wan Kim, Gyeong‐Won Lee, Jong Seok Lee, Gee‐Chen Chang, Sung Sook Lee, Yu‐Feng Wei, Yun Gyoo Lee, Gianluca Laus, Barbara Collins, Francesca Pisetzky, Leora Horn

    Argitaratua 2019
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis

    Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis nork Pei-Fang Hung, Tse‐Ming Hong, Che‐Chang Chang, Chung‐Lieh Hung, Yuan-Ling Hsu, Yih‐Leong Chang, Chen‐Tu Wu, Gee‐Chen Chang, Nei‐Li Chan, Sung‐Liang Yu, Pan‐Chyr Yang, Szu‐Hua Pan

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: